h1.qusth1 { display: none !important; }

QUESTION OF THE WEEK

Dr. Donovan's Articles

QUESTION OF HAIR BLOGS


Body Hair transplantation

Body hair transplantation ("BHT") is a newer technique of hair transplantation whereby donor hair is taken from any area other than the scalp.
Donor hair used for BHT includes beard, chest, leg and arms. This photo shows follicles freshly isolated from the chest. They will be transplanted into the scalp.
The survival of follicles from sites other than the scalp may be less than for the scalp. Chest and beard follicles generally have higher survival than leg and arm hair.


This article was written by Dr. Jeff Donovan, a Canadian and US board certified dermatologist specializing exclusively in hair loss.
Share This
No Comments









Treatment of Lichen planopilaris (LPP): What's available?

Treating Lichen Planopilaris (LPP)

I'm often asked how lichen planopilaris is best treated. There are many treatments for lichen planopilaris. These include topical, injection forms, oral (pill) forms and laser. Patients should always keep in mind that the main goal of treatment is to stop the condition- regrowth or improvements in hair density do not often occur.

 

1. TOPICAL TREATMENTS

Topical steroids and topical calcineurin inhibitors are two important topical treatments to consider when treating lichen planopilaris. 

Topical steroids range from weak to very strong (potent). Generally potent topical steroids are needed for a period of time and one of the most common such ones is Clobetasol. Topical steroids are available as creams, lotions, sprays, foams and shampoos. Side effects include thinning of the skin, dilatation of blood vessels and others.

Topical calcineurin inhibitors are not generally as effective but have a distinct benefit in that they do not thin the skin. Tacrolimus (Protopic) and Pimecrolimus (Elidel) are two examples.

 

2. STEROID INJECTIONS

Steroid injections can be very helpful in LPP. Choosing the appropriate concentration for a given patient is important as one of the side effects of excessive steroid is atrophy or "dents/depressions" in the scalp. These can even happen when the right concentration was used and the patient's scalp is just sensitive to the medications. Other side effects are possible (but fairly rare) but one should review all side effects with their physician. Some women for example may notice irregular periods for a month of two after.

 

3. ORAL TREATMENTS (Pills)

Oral treatments are among the most important to carefully review with one's dermatologist. Not everyone needs them but in my opinion a high proportion do require them for various periods of time. The exact oral treatment to start with depends on several factors but may include oral doxycycline/tetracycline, or oral hydroxychloroquine. Treatments such as mycophenolate mofetil, methotrexate, cyclosporine, prednisone may be needed. Side effects differ according to which treatment is used - so all patients considering starting these medications should review side effects with their dermatologist.

 

4. LASERS

The 308 nm excimer laser can also be considered in some forms of LPP. Other laser devices, such as the 655 nm red (low level laser therapy) lasers may also benefit but not likely to the same degree as the 308 nm lasers.

 

Conclusions

There are many treatments for lichen planopilaris. Topical steroids and steroid injections are important for individuals with very limited disease. However, more advanced disease requires oral treatments, in combination with topical and/or injections. If disease improves and stabilizes, one may reduce medications. If the conditions worsens more aggressive treatments are needed.  For example if a patient using topical steroids is still loosing hair I often move up to doxycycline + topical steroids. If the patient using doxycycline or hydroxychloroquine is still not improving, we may start methotrexate or mycophenolate.


This article was written by Dr. Jeff Donovan, a Canadian and US board certified dermatologist specializing exclusively in hair loss.
Share This
8 Comments

WNTS and Hair Loss: A closer look at SM04554

Samumed is a US based company which focuses on how drugs targeting the Wnt pathway can be used in human disease. 

This year at the American Academy of Dermatology Annual meeting in Orlando, Samumed presented data on it's Wnt drug SM04554. Study involved 49 men with adrogenetic alopecia who were treated with either a placebo drug or 0.15 % or 0.25 % concentrations. 

Results at day 135 showed that the 0.15 % concentration was more effective than the 0.25 % solution - and both were more effective than the placebo. 

Conclusion 

This is a preliminary study but suggests that exploration of drugs that target the Wnt pathway may be worthwhile to explore. It's clear that Wnt signalling is reduced/impaired in androgenetic alopecia.

 

Reference 

Yazici et al. Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial. 

DOI: http://dx.doi.org/10.1016/j.jaad.2016.02.544


This article was written by Dr. Jeff Donovan, a Canadian and US board certified dermatologist specializing exclusively in hair loss.
Share This
No Comments

A Global Curriculum in Hair Loss

Heading back home to Vancouver this weekend to join the International Hair Restoration Platform (IHRP) for their conference in Vancouver.

I'm honoured to have the opportunity to lecture Sunday in a unique course for professionals in the hair industry. Our clinic has an interest not only in clinical research and treatment as it pertains to hair loss - but also education. I'm excited to join the IHRP this weekend as we expand our educational efforts to stylists, barbers, and hairdressers.


This article was written by Dr. Jeff Donovan, a Canadian and US board certified dermatologist specializing exclusively in hair loss.
Share This
No Comments








Blogs by Topic





Share This
-->